Imagen de Portada

Can the Unit Size Predict Outcomes? Testing for Informativeness in Three‐Level Designs

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Samuel Anyaso‐Samuel, Somnath Datta, Eva Roos, Jaakko Nevalainen
Formato:	Artículo Open Access
Publicado:	Wiley 2025
Materias:	Statistics in Medicine
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Multiblock partial least squares and rank aggregation: Applications to detection of bacteriophages associated with antimicrobial resistance in the presence of potential confounding factors
por: Shoumi Sarkar, et al.
Publicado: (2024)

Integrating Multiple Clustering Techniques and Performance Measures via Ranking for scRNA‐Seq Data
por: Owen Visser, et al.
Publicado: (2025)

Comparing two hazard curves when there is a treatment time‐lag effect
por: Xiaoxi Zhang, et al.
Publicado: (2024)

Nonparametric estimation of a state entry time distribution conditional on a "past" state occupation in a progressive multistate model with current status data
por: Anyaso-Samuel, Samuel, et al.
Publicado: (2024)

Modelling and Predicting Population‐Level Growth With Individual‐Level Information
por: Tuuli Kauppala, et al.
Publicado: (2026)

Sample Size Calculation for the ROCI Design
por: Henry Bern, et al.
Publicado: (2026)

Comments on “Sample Size Adaptation Designs and Efficiency Comparison With Group Sequential Designs”
por: Meinhard Kieser, et al.
Publicado: (2025)

MARGO: Machine Learning‐Assisted Adaptive Randomization for Group Sequential Trials Based on Overlap Weights
por: Yeonhee Park, et al.
Publicado: (2025)

Testing and Quantifying Site‐Level Variability in Diagnostic Sensitivity of an Anchor Variable
por: Seungchul Baek, et al.
Publicado: (2026)

Validation of a Risk‐Prediction Model in the Presence of Outcome Misclassification
por: Runjia Zou, et al.
Publicado: (2026)

BEAM: Bayesian Hybrid Design With Adaptive Sample Size Through Multisource Exchangeability Modeling
por: Feng Tian, et al.
Publicado: (2025)

Overcoming Model Uncertainty — How Equivalence Tests Can Benefit From Model Averaging
por: Niklas Hagemann, et al.
Publicado: (2025)

Optimal Allocation of Observations in Stepped‐Wedge and Other Cluster Studies With Correlated Cluster‐Period Effects
por: Alan J. Girling, et al.
Publicado: (2025)

Handling Missing Outcome Data in Cluster Randomized Trials With Both Individual‐ and Cluster‐Level Dropout
por: Analissa Avila, et al.
Publicado: (2025)

Bayesian Estimation of Hierarchical Linear Models From Incomplete Data: Cluster‐Level Interaction Effects and Small Sample Sizes
por: Dongho Shin, et al.
Publicado: (2025)

Sample Size Re‐Estimation in Blinded Hybrid‐Control Design Using Inverse Probability Weighting
por: Masahiro Kojima, et al.
Publicado: (2026)

Network Meta‐Analysis With Individual Participant‐Level Data of Time‐to‐Event Outcomes Using Cox Regression
por: Kaiyuan Hua, et al.
Publicado: (2025)

Using Propensity Score Weighting With Clustered Data When the Treatment Is Applied at the Level of the Cluster and Outcomes Are Assessed at the Level of the Individual: The Observational Analog of Cluster Randomization Trials
por: Peter C. Austin
Publicado: (2026)

Designing Stepped Wedge Cluster Randomized Trials With a Baseline Measurement of the Outcome
por: Kendra Davis‐Plourde, et al.
Publicado: (2025)

BCH‐GEE Approach to Examine the Association Between Time‐Varying Food Environment Classes and Multi‐Level Health Outcomes
por: Kelsey A. L. Alexovitz, et al.
Publicado: (2026)

Asymptotic Confidence Interval, Sample Size Formulas and Comparison Test for the Agreement Intra‐Class Correlation Coefficient in Inter‐Rater Reliability Studies
por: Abderrahmane Bourredjem, et al.
Publicado: (2024)

DOD ‐ SSR : An Adaptive Seamless Phase II / III Design With Dose Optimization Decision and Sample Size Re‐estimation
por: Meizi Liu, et al.
Publicado: (2025)

A hybrid approach to sample size re‐estimation in cluster randomized trials with continuous outcomes
por: Samuel K Sarkodie, et al.
Publicado: (2024)

Adaptive Seamless Phase II / III Randomization Test Considering Treatment Group Selection Based on Short–Term Binary Outcomes
por: Funato Sato, et al.
Publicado: (2026)

A Generalized Phase I/II Dose Optimization Trial Design With Multi‐Categorical and Multi‐Graded Outcomes
por: Yichen Yan, et al.
Publicado: (2025)

Analysis of Covariance in General Factorial Designs Through Multiple Contrast Tests Under Variance Heteroscedasticity
por: Matthias Becher, et al.
Publicado: (2025)

A Novel Stratified Analysis Method for Testing and Estimating Overall Treatment Effects on Time‐To‐Event Outcomes Using Average Hazard With Survival Weight
por: Zihan Qian, et al.
Publicado: (2025)

Identifying Less Burdensome and More Cost‐Efficient Incomplete Stepped Wedge Designs for Continuous Outcomes Collected via Repeated Cross‐Sections
por: Ehsan Rezaei‐Darzi, et al.
Publicado: (2025)

Expected Value of Sample Information Calculations for Risk Prediction Model Development
por: Abdollah Safari, et al.
Publicado: (2026)

Sample Size Adjustment in Sequential Multiple Assignment Randomized Trials
por: Liwen Wu, et al.
Publicado: (2025)

Sample Size and Power Calculations With Win Measures Based on Hierarchical Endpoints
por: Huiman Barnhart, et al.
Publicado: (2025)

Regional Consistency Evaluation and Sample Size Calculation Under Two MRCTs
por: Kunhai Qing, et al.
Publicado: (2025)

Confidence Intervals and Sample Size for the ICC in Two‐Way ANOVA Models
por: Dipro Mondal, et al.
Publicado: (2025)

A Note on the Sample Size Formula for a Win Ratio Endpoint
por: Se Yoon Lee
Publicado: (2025)

Modelling Volume‐Outcome Relationships in Health Care
por: Maurilio Gutzeit, et al.
Publicado: (2025)

Sample Size Calculation in Dose Optimization Trials Using the Margin of Practical Non‐Inferiority
por: Hakim‐Moulay Dehbi, et al.
Publicado: (2025)

Causal Inference With Outcomes Truncated by Death and Missing Not at Random
por: Wei Li, et al.
Publicado: (2025)

An Empirical Assessment of the Cost of Dichotomization of the Outcome of Clinical Trials
por: Erik W. van Zwet, et al.
Publicado: (2026)

Power and Sample Size Calculations for Cluster Randomized Hybrid Type 2 Effectiveness‐Implementation Studies
por: Melody A. Owen, et al.
Publicado: (2025)

Linear Mixed Modeling of Federated Data When Only the Mean, Covariance, and Sample Size Are Available
por: Marie Analiz April Limpoco, et al.
Publicado: (2024)